LAKE FOREST, Ill., Feb. 26 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global hospital products company, today announced a new national agreement with HealthTrust Purchasing Group, LP (HealthTrust). The multi-year contract will provide HealthTrust member organizations with access, on a non-exclusive basis, to Hospira's general-purpose medication infusion devices, related sets and disposables, along with intravenous (I.V.) solutions, nutritionals and drug-delivery products.
Through existing agreements, Hospira already provides pain-management infusion pumps to HealthTrust members, and infusion devices, I.V. solutions and equipment to members of Consorta -- a group purchasing organization (GPO) that joined HealthTrust in 2007.
"Hospira's products and services can help HealthTrust's members meet their goals -- from increasing patient safety to reducing costs and improving caregiver productivity," said Pete Baker, vice president and general manager, Commercial Service Operations, Hospira. "We look forward to developing strong relationships with HealthTrust's member healthcare institutions."
The new agreement includes Hospira's general-purpose medication infusion technologies, such as the Plum A+(R) and next-generation Symbiq(R) infusion systems with Hospira MedNet(R) safety software. These products play a critical role in improving patient safety as well as enhancing quality of care and clinician workflow. The contract also provides access to Hospira's I.V. solutions and associated equipment portfolio, including the company's more environmentally preferable VisIV(R) container for I.V. solutions. This contract represents the first opportunity for Hospira to provide access to these products to HealthTrust members.
HealthTrust Purchasing Group, headquartered in Brentwood, Tennessee, is a group purchasing organization that supports over 3800 not-for-profit and for-profit facilities, which include acute care hospitals, ambulatory surgery centers, physician practices, and alternate care sites. With an annual purchasing volume by its members of more than $13 billion, HealthTrust is committed to obtaining the best price for clinically-recommended products, ensuring their timely delivery and continuously evaluating and improving its services to the patients, physicians and clinicians it serves. HealthTrust is located at 155 Franklin Road, Suite 400, Brentwood, TN 37027 Website: http://www.healthtrustpg.com.
Hospira, Inc. is a global specialty pharmaceutical and medication
delivery company dedicated to Advancing Wellness(TM). As the world leader
in specialty generic injectable pharmaceuticals, Hospira offers one of the
broadest portfolios of generic acute-care and oncology injectables, as well
as integrated infusion therapy and medication management solutions. Through
its products, Hospira helps improve the safety, cost and productivity of
patient care. The company is headquartered in Lake Forest, Ill., and has
more than 14,000 employees. Learn more at http://www.hospira.com.
Private Securities Litigation Reform Act of 1995 --
A Caution Concerning Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Hospira cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological and other factors that may affect Hospira's operations and may cause actual results to be materially different from expectations include the risks and uncertainties set forth under the heading "Item 1 Business -- Risk Factors" in Hospira's Annual Report on Form 10-K for the year ended Dec. 31, 2006, filed with the Securities and Exchange Commission, which are incorporated by reference. Hospira undertakes no obligation to release publicly any revisions to forward-looking statements as the result of subsequent events or developments.
|SOURCE Hospira, Inc.|
Copyright©2008 PR Newswire.
All rights reserved